Evidence map

TrialDiabetes care2015

Empagliflozin reduces blood pressure in patients with type 2 diabetes and hypertension.

Ilkka Tikkanen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

240 papers cite itlatest 60 shown

2015
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

3 trials

Full record →Abstract, authors, funding and every citing paper · PMID 25271206